Business & Finance
AstraZeneca divests global commercial rights for Losec to Cheplapharm for USD243m
2 October 2019 - AstraZeneca Plc (LON:AZN), a global, science-led biopharmaceutical company, announced on Tuesday that it has agreed to sell the global commercial rights, excluding China, Japan, the U...
Bactiguard announces global license agreement with Zimmer Biomet for orthopaedic trauma implants
30 September 2019 - Bactiguard Holding AB (Bactiguard) (STO:BACTIB),a medical device company, announced on Friday that it has entered into an exclusive, global license agreement for orthopaedic trauma...
Theradiag generates revenues of EUR5.0m for H1 2019
25 September 2019 - In vitro diagnostics company Theradiag (Paris:ALTER) (ISIN:FR0004197747) said on Tuesday that its board of directors announced revenues of EUR5.0m for the six months ended 30 June ...
Pfizer's board approves USD0.36 per share dividend for quarter
25 September 2019 - The board of directors of healthcare company Pfizer Inc (NYSE:PFE) declared an unchanged dividend of USD0.36 per share on the company's common stock, it declared on Tuesday.Ho...
Themis Raises EUR 40m in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline
24 September 2019 - - Austrian immunomodulation therapies developer Themis has closed a Series D financing round totaling EUR 40m (USD 44m), the company said.

The round was co-led by...
Hansoh Pharmaceutical Group Company collaborates with Atomwise
13 September 2019 - It was reported yesterday that Hansoh Pharmaceutical Group Company, a biopharmaceutical company in China, has collaborated with Atomwise, a company focused on artificial intelligen...